BACKGROUNDS AND STUDY AIMS: At the time of diagnosis most @entity1 with @entity788 are still irresectable for cure. The aim of this study was to evaluate surgical palliation, in particular against the background of endoscopic stent placement. @entity1 AND METHODS: This retrospective study analyses the therapeutic results in 107 @entity1 with an irresectable @entity3123 operated on between 1990 and 1998. RESULTS: 104 @entity1 showed primary therapeutic success with adequate bile drainage. In 97 % a simultaneous gastrojejunostomy was performed. The overall complication rate was 24 % and the hospital mortality 3.7 %. Median survival after surgical treatment was 201 days. CONCLUSIONS: Because of a decrease in perioperative morbidity and mortality, surgical palliation of irresectable @entity3123 still remains an effective therapy, especially for @entity1 expected to survive 6 months or more. The surgical procedure offers the better chance for long-term palliation of @entity3883 and @entity9727 compared to the endoscopic approach. However, to consider both, the surgical and the endoscopic treatment, complementing each other, seems to be important to guarantee optimal palliation for the individual @entity1 .

[Role of surgical biliary bypass for palliation of XXXX - a retrospective study of 107 cases].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity3123 :: ('MESH:C562463', 'Disease') :: ['pancreatic carcinoma'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatic cancer'] @entity3883 :: ('MESH:D041781', 'Disease') :: ['obstructive jaundice'] @entity9727 :: ('MESH:D004380', 'Disease') :: ['duodenal obstruction']
@entity788 :: (MESH:D010190,Disease) :: ['pancreatic cancer']
